Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rosetta Genomics Ltd (NASDAQ:ROSG)

3.22
Delayed Data
As of 3:59pm ET
 -0.57 / -15.04%
Today’s Change
3.16
Today|||52-Week Range
18.60
-36.11%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close3.79
Today’s open3.85
Day’s range3.16 - 3.87
Volume329,588
Average volume (3 months)28,358
Market cap$7.1M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+10.85%
Earnings growth (this year)+47.39%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+523.06%
P/E ratio--
Price/Sales2.25
Price/Book3.96

Competitors

 Today’s
change
Today’s
% change
RGBPRegen BioPharma Inc-0.00-5.00%
CLSNCelsion Corp+0.00+1.52%
RXIIRxi Pharmaceuticals ...-0.01-1.40%
XTNTXtant Medical Holdin...-0.00-0.73%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateApril 3, 2017
EPS forecast (this quarter)-$1.38
Annual revenue (last year)$8.3M
Annual profit (last year)-$17.3M
Net profit margin-209.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, Tel Aviv

Forecasts


Search for Jobs